Literature DB >> 19664632

Fibroblast growth factor 21 reduces the severity of cerulein-induced pancreatitis in mice.

Charis L Johnson1, Jacqueline Y Weston, Sami A Chadi, Elena N Fazio, Murray W Huff, Alexei Kharitonenkov, Anja Köester, Christopher L Pin.   

Abstract

BACKGROUND & AIMS: Fibroblast growth factor 21 (FGF21) acts as a hormonal regulator during fasting and is involved in lipid metabolism. Fgf21 gene expression is regulated by peroxisome proliferator-activated receptor (PPAR)-dependent pathways, which are enhanced during pancreatitis. Therefore, the aim of this study was to investigate FGF21's role in pancreatic injury.
METHODS: Fgf21 expression was quantified during cerulein-induced pancreatitis (CIP) or following mechanical or thapsigargin-induced stress through Northern blot analysis, in situ hybridization, and quantitative reverse transcription polymerase chain reaction. FGF21 protein was quantified by Western blot analysis. Isolated acinar cells or AR42J acinar cells were treated with recombinant FGF21 protein, and extracellular regulated kinase 1/2 activation was examined. The severity of CIP was compared between wild-type mice and mice overexpressing FGF21 (FGF21Tg) or harboring a targeted deletion of Fgf21 (Fgf21(-/-)).
RESULTS: Acinar cell Fgf21 expression markedly increased during CIP and following injury in vitro. Purified FGF21 activated the extracellular regulated kinase 1/2 pathway in pancreatic acinar cells. The severity of CIP is inversely correlated to FGF21 expression because FGF21Tg mice exhibited decreased serum amylase and decreased pancreatic stellate cell activation, whereas Fgf21(-/-) mice had increased serum amylase and tissue damage. The expression of Fgf21 was also inversely correlated to expression of Early growth response 1, a proinflammatory and profibrotic transcription factor.
CONCLUSIONS: These studies suggest a novel function for Fgf21 as an immediate response gene protecting pancreatic acini from overt damage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19664632     DOI: 10.1053/j.gastro.2009.07.064

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  68 in total

Review 1.  Endocrine fibroblast growth factors 15/19 and 21: from feast to famine.

Authors:  Matthew J Potthoff; Steven A Kliewer; David J Mangelsdorf
Journal:  Genes Dev       Date:  2012-02-02       Impact factor: 11.361

2.  FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis.

Authors:  Ffolliott M Fisher; Sandra Kleiner; Nicholas Douris; Elliott C Fox; Rina J Mepani; Francisco Verdeguer; Jun Wu; Alexei Kharitonenkov; Jeffrey S Flier; Eleftheria Maratos-Flier; Bruce M Spiegelman
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

Review 3.  Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.

Authors:  Chiara Degirolamo; Carlo Sabbà; Antonio Moschetta
Journal:  Nat Rev Drug Discov       Date:  2015-11-16       Impact factor: 84.694

4.  FGF21 Is an Exocrine Pancreas Secretagogue.

Authors:  Katie C Coate; Genaro Hernandez; Curtis A Thorne; Shengyi Sun; Thao D V Le; Kevin Vale; Steven A Kliewer; David J Mangelsdorf
Journal:  Cell Metab       Date:  2017-01-12       Impact factor: 27.287

5.  The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue.

Authors:  Andrew C Adams; Chaofeng Yang; Tamer Coskun; Christine C Cheng; Ruth E Gimeno; Yongde Luo; Alexei Kharitonenkov
Journal:  Mol Metab       Date:  2012-08-28       Impact factor: 7.422

6.  Loss of FGF21 in diabetic mouse during hepatocellular carcinogenetic transformation.

Authors:  Quan Zhang; Yan Li; Tingting Liang; Xuemian Lu; Xingkai Liu; Chi Zhang; Xin Jiang; Robert C Martin; Mingliang Cheng; Lu Cai
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

Review 7.  Fibroblast growth factor 21 in chronic kidney disease.

Authors:  Paulo Giovanni de Albuquerque Suassuna; Rogério Baumgratz de Paula; Hélady Sanders-Pinheiro; Orson W Moe; Ming-Chang Hu
Journal:  J Nephrol       Date:  2018-11-14       Impact factor: 3.902

8.  FGF21 and glycemic control in patients with T1D.

Authors:  Simone Rosell Rask; Troels Krarup Hansen; Mette Bjerre
Journal:  Endocrine       Date:  2019-08-01       Impact factor: 3.633

9.  Changes and significance of serum FGF21 in children with primary nephrotic syndrome and chronic renal failure.

Authors:  Nian Wei; Zhi-Qiang Guo; Fang Yang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

Review 10.  Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease.

Authors:  Nobuyuki Itoh
Journal:  Cell Tissue Res       Date:  2010-08-24       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.